What it's for (Indications)
- Lantigen-B is indicated for the prevention of recurrent respiratory tract infections in both adults and children.
- It is primarily used as an immunostimulant to bolster the body's natural defense mechanisms against common bacterial pathogens responsible for respiratory illnesses, such as *Streptococcus pneumoniae*, *Haemophilus influenzae*, *Staphylococcus aureus*, and *Klebsiella pneumoniae*.
- This therapeutic approach aims to reduce the frequency, severity, and duration of respiratory infections, thereby diminishing the need for antibiotic use and improving overall quality of life for individuals prone to such conditions.
- Its application is generally considered in patients with a history of repeated episodes of upper and lower respiratory tract infections, including rhinitis, pharyngitis, laryngitis, tracheitis, bronchitis, and otitis media.
- The utility of Lantigen-B extends to situations where a prophylactic measure is desired to enhance immune resilience against bacterial insults rather than treating an active, acute infection.
- It serves as an adjunctive therapy within a comprehensive management plan for individuals with compromised respiratory immune function or heightened susceptibility to bacterial respiratory pathogens.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage regimen for Lantigen-B typically involves an oral administration, and specific instructions may vary based on the patient's age and the prescribing physician's discretion. For adults, the usual recommended dose is 15 drops or 1 capsule daily for a period of 20-30 consecutive days. This initial course may be followed by a treatment-free interval, commonly 2-3 weeks, after which the entire cycle can be repeated for a total of 2-3 months over a season, particularly during periods of higher infection risk (e.g., autumn and winter). For pediatric patients, specifically children, the dosage is often adjusted; for instance, children might receive 7-10 drops daily for the same duration. The drops can be administered directly or diluted in a small amount of water or other liquid. It is crucial to adhere strictly to the prescribed dosage and duration of treatment to maximize therapeutic efficacy and minimize potential adverse effects. The administration should ideally occur in the morning, before breakfast. It is important not to exceed the recommended dose without consulting a healthcare professional. Should a dose be missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped. Double doses are not recommended. Patients should consult their physician for personalized dosing guidance. |
Safety & Warnings
Common Side Effects
- Like all medicinal products, Lantigen-B may cause side effects, although not everybody gets them.
- The majority of reported adverse reactions are generally mild and transient, resolving without specific intervention.
- Common side effects often involve the gastrointestinal system and may include nausea, vomiting, abdominal discomfort, diarrhea, or constipation.
- Headache and dizziness have also been reported with some frequency.
- Allergic reactions, such as skin rashes, urticaria (hives), itching, and erythema, can occur, indicating a hypersensitivity response to one of the components.
- In rare instances, more severe systemic reactions, including angioedema or bronchospasm, could manifest, requiring immediate medical attention.
- Mild, transient fever or flu-like symptoms might also be experienced, which can be attributed to the immune system's activation.
- If any of these side effects persist, worsen, or cause significant discomfort, patients should be advised to contact their healthcare provider immediately.
- Furthermore, any new or unexpected symptoms that develop during treatment should be reported.
- The benefits of preventing recurrent respiratory infections should always be weighed against the potential risks of side effects, and this discussion should occur between the patient and their prescribing physician.
Serious Warnings
- Black Box Warning: Lantigen-B, as an oral bacterial lysate immunostimulant, does not carry a formal FDA-mandated Black Box Warning. Black Box Warnings are typically reserved for drugs that pose significant risks of serious or life-threatening adverse effects, and such a level of concern has not been identified or associated with Lantigen-B based on available clinical data and regulatory assessments. However, despite the absence of a formal boxed warning, several serious warnings and precautions must be carefully considered by healthcare professionals and patients. **Serious Warnings**: 1. **Hypersensitivity Reactions**: Although rare, severe allergic reactions, including anaphylaxis, can occur. Patients should be advised to seek immediate medical attention if they experience symptoms such as difficulty breathing, swelling of the face, lips, tongue, or throat, severe rash, or dizziness. 2. **Autoimmune Disorders**: Caution is strongly advised in patients with existing autoimmune conditions (e.g., systemic lupus erythematosus, rheumatoid arthritis). Immunostimulants could theoretically exacerbate these conditions. The decision to use Lantigen-B in such patients must be made after a careful risk-benefit analysis by a specialist. 3. **Acute Infections**: Lantigen-B is not indicated for the treatment of acute infections, especially those accompanied by high fever. Its administration during an active febrile illness should be avoided, as it is designed for prophylactic immune modulation, not acute therapeutic intervention. 4. **Pediatric Use**: The safety and efficacy in infants under 1 year of age have not been fully established, and use in this population should be under strict medical supervision and only when clearly indicated. 5. **Pregnancy and Lactation**: Data on the use of Lantigen-B during pregnancy and breastfeeding are insufficient. Therefore, it should only be used if the potential benefit justifies the potential risk to the fetus or infant, and under strict medical guidance. Patients should be educated on recognizing signs of serious adverse reactions and when to seek urgent medical care. Healthcare providers should ensure a comprehensive patient history is obtained to identify any contraindications or high-risk factors.
- Patients should be advised of several important warnings and precautions before initiating or continuing treatment with Lantigen-B.
- Firstly, individuals with known hypersensitivity or allergic reactions to any of the active ingredients or excipients contained within Lantigen-B should not use this product.
- Acute infections, particularly those accompanied by fever, should be fully resolved before commencing treatment with Lantigen-B, as its primary role is prophylaxis and immune modulation rather than acute infection treatment.
- Administration during an acute febrile illness may not only be ineffective but could potentially exacerbate symptoms in rare cases.
- Caution is advised in patients with autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, or multiple sclerosis, as immunostimulants theoretically could trigger or worsen autoimmune responses.
- The safety and efficacy of Lantigen-B in pregnant or breastfeeding women have not been definitively established, and therefore, its use in these populations should be approached with extreme caution and only if clearly indicated by a physician after a thorough risk-benefit assessment.
- Children under the age of 1 year should generally not be treated with Lantigen-B without explicit medical guidance.
- Patients experiencing severe or persistent adverse reactions, including signs of a severe allergic reaction (e.
- g.
- , difficulty breathing, swelling of the face or throat, severe rash), should discontinue the medication immediately and seek urgent medical attention.
- Patients should inform their healthcare provider about all current medications, including over-the-counter drugs, herbal supplements, and other vaccines, to avoid potential interactions.
How it Works (Mechanism of Action)
Lantigen-B exerts its therapeutic effects by stimulating the body's natural immune defense mechanisms, making it an immunostimulant composed of bacterial lysates. These lysates are essentially inactivated or fragmented components of common respiratory pathogens, such as *Streptococcus pneumoniae*, *Haemophilus influenzae*, *Staphylococcus aureus*, and *Klebsiella pneumoniae*. Upon oral administration, these bacterial antigens are absorbed through the intestinal mucosa, where they interact with gut-associated lymphoid tissue (GALT). This interaction leads to the activation of various immune cells, including macrophages, T-lymphocytes, and B-lymphocytes, initiating a cascade of immune responses. The mechanism is thought to involve both non-specific and specific immunological pathways. Non-specific immunity is enhanced through increased phagocytic activity of macrophages and neutrophils, elevated natural killer (NK) cell activity, and enhanced production of cytokines (e.g., interferons, interleukins) that play critical roles in antiviral and antibacterial defense. Furthermore, exposure to these bacterial antigens can lead to the production of specific antibodies, particularly secretory IgA, which provides localized immune protection on mucosal surfaces of the respiratory tract. This heightened immune surveillance and readiness translate into an improved ability to recognize and neutralize invading pathogens, thereby reducing the incidence, severity, and duration of subsequent respiratory infections. The goal is to 'prime' the immune system to react more effectively and rapidly when faced with actual bacterial challenges.
Commercial Brands (Alternatives)
No other brands found for this formula.